2004 News Releases

• News Release - December 31, 2004
  Standard of ethics strengthened in Rx&D Code of Conduct. Read More

• News Release - December 17, 2004
  Rx&D is reacting to the Quebec government's draft drug policy. Read More

• Speech - December 1, 2004
  Speech by Jean-Michel Halfon, Immediate Past-Chair of Rx&D, to the Canadian Chamber of Commerce, Toronto, November 23, 2004. Read More

• Op-Ed - December 2, 2004
  The Journal Pioneer (P.E.I.) - Rx&D President Russell Williams says access to new medicines is paramount for Canadian patients. Read More

• Article - November 18, 2004
  Internet pharmacies find some problems according to Health Canada report. Read More

• News Release - November 17, 2004
  New Chairman of the Board of Directors of Rx&D Read More

• News Release - September 17, 2004
  Rx&D President Russell Williams says Canada's research-based pharmaceutical community is ready to participate in the Ministerial Task Force that will examine various aspects of a national pharmaceutical strategy. Read More

• Op-Ed - September 13, 2004
  Rx&D President Russell Williams says a pan-Canadian pharmaceutical strategy is necessary for the sustainability of the Canadian health care system.
  Read More

• News Release - September 13, 2004
  Rx&D President Russell Williams hopes the First Ministers' Meeting in Ottawa will lead to the creation of a Pan-Canadian pharmaceutical strategy. Read More

• Letter-to-the-Editor - September 7, 2004
  The New Hamburg Independent - Rx&D President Russell Williams writes about the importance of research and development in Canada and the fact that generic products sold in Canada are priced higher than in other countries. Read More

• Letter-to-the-Editor - September 2, 2004
  The Toronto Star - Rx&D President Russell Williams explains the importance of patent protection in Canada for the pharmaceutical industry searching new medicines for patients. Read More

• News Release - September 1, 2004
  Rx&D hopes the Premiers meeting underway in Toronto, Ontario, will lead the way for discussions and solutions for our health care systems and for patients. Read More

• Op-Ed - July 30, 2004
  Rx&D President Russell Williams wrote an Opinion-Editorial (Op-Ed) in which he asks premiers to look at the value of medicines to relief the Canadian health care system of his burden. Mr. Williams also stresses the need to implement an innovation policy and the need to take action on Internet pharmacies. Read More

• News Release - July 29, 2004
  Rx&D news release on the Council of the Federation meeting on health care in Niagara-on-the-Lake, Ontario. Read More

• News Release - July 28, 2004
  The Patented Medicine Prices Review Board (PMPRB) released figures on research and development (R&D) by the member companies of Rx&D. These figures confirm the need for an invigorating Innovation Agenda. Read More

• Letter-to-the-Editor - July 27, 2004
  Le Soleil (Québec city) - Rx&D President Russell Williams explains that Rx&D support the optimal use and the optimal access to medicines in Quebec. Read More

• Letter-to-the-Editor - July 21, 2004
  The Globe and Mail - Rx&D President Russell Williams wrote to the Editor of The Globe and Mail in response to Jeffrey Simpson's commentary “Health-Care Advice for Premiers: Start Without The Feds” (July 16). Read More

• Op-Ed - July 23, 2004
  The Ottawa Citizen - Rx&D President Russell Williams explains the impact of Internet Pharmacy for patients in Canada and stresses the need for governments to take action. Read More

• Letter-to-the-Editor - June 26, 2004
  Letter sent to The Globe and Mail by Rx&D President Russell Williams in response to the Canadian Institute for Health Information (CIHI) report on drug expenditures in Canada in 2003. The letter was also sent to all elected officials across Canada. Read More

• Letter-to-the-Editor - June 10, 2004
  Letter sent to La Presse (Montreal) and Le Soleil (Quebec city) by Rx&D President Russell Williams in response to an article published on June 7th quoting the President of Quebec Council on Medication (Conseil québécois du médicament) assaying that 90% of new therapies would not be covered by Quebec provincial regime. The letter was also sent to all Quebec MNAs and to Quebec Premier Jean Charest.
  Le Soleil

La Presse

• The Innovative Pharmaceutical Industry - Facts You Should Know - Read More

• News Release - May 20, 2004
  Symposium on the optimum use of medication: patient welfare must come first according to Rx&D. Read More

• Speech - May 12, 2004
  Rx&D Remarks to the Senate Foreign Affairs Committee on Bill C-9, May 12, 2004. Read More

• Letter-to-the-Editor - April 28, 2004
  National Post - With the passage of amendments to Bill C-9 (The Jean Chretien Pledge to Africa Act). Read More

• Letter-to-the-Editor - April 28, 2004
  Times and Transcript - With the passage of amendments to Bill C-9 (The Jean Chretien Pledge to Africa Act). Read More

• News Release - March 24, 2004
  Rx&D: Federal Budget Positive First Step; Gaps Remain. Read More

• News Release - March 9, 2004
  New President at the Helm of Rx&D. Read More

• News Release - February 26, 2004
  Research-Based Pharmaceutical Companies Support Canada's Efforts to Provide Medicines to Countries in Need. Read More

• News Release - February 2, 2004
  The Speech from The Throne - Research and Development- The Way of the Future for Developing Countries and for Canada, says Rx&D. Read More